Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › PCSK9 targeting oligonucleotides for treating hypercholesterolemia and related conditions

PCSK9 targeting oligonucleotides for treating hypercholesterolemia and related conditions

US Patent 11566248 · Granted Jan 31, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS62025
Compositions and methods for inhibiting LPA expression2025
Compositions and methods for inhibiting LPA expression2025
Compositions and methods for modulating APOC3 expression2025
Compositions and methods for modulating PNPLA3 expression2024
Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS62024
Compositions and methods for inhibiting transmembrane serine protease 6 (TMPRSS62024
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by d2024
Methods and compositions for the specific inhibition of glycolate oxidase (HAO1)2024
Methods and compositions for the specific inhibition of alpha-1 antitrypsin by d2023
Methods and compositions for the specific inhibition of Complement Component 5(C2023
Methods and compositions for the specific inhibition of transthyretin (TTR) by d2023